0001790134-25-000003.txt : 20250814 0001790134-25-000003.hdr.sgml : 20250814 20250814095640 ACCESSION NUMBER: 0001790134-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250814 DATE AS OF CHANGE: 20250814 EFFECTIVENESS DATE: 20250814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RxWare, Inc. CENTRAL INDEX KEY: 0001790134 ORGANIZATION NAME: EIN: 464267954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-554698 FILM NUMBER: 251215090 BUSINESS ADDRESS: STREET 1: 1313 NORTH MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 857-246-9674 MAIL ADDRESS: STREET 1: 1313 NORTH MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: HelpAround, Inc. DATE OF NAME CHANGE: 20191002 D 1 primary_doc.xml X0708 D LIVE 0001790134 RxWare, Inc. 1313 NORTH MARKET STREET SUITE 1000 WILMINGTON DE DELAWARE 19801 218-392-4373 DELAWARE HelpAround, Inc. Corporation true Shlomi Aflalo c/o RxWare, Inc. 1313 North Market Street, Suite 1000 Wilmington DE DELAWARE 19801 Executive Officer Director Raeanna Lewarne c/o RxWare, Inc. 1313 North Market Street, Suite 1000 Wilmington DE DELAWARE 19801 Executive Officer Director Farhan Ashraf c/o RxWare, Inc. 1313 North Market Street, Suite 1000 Wilmington DE DELAWARE 19801 Director Harry Totonis c/o RxWare, Inc. 1313 North Market Street, Suite 1000 Wilmington DE DELAWARE 19801 Director Adam Fine c/o RxWare, Inc. 1313 North Market Street, Suite 1000 Wilmington DE DELAWARE 19801 Director David Matias c/o RxWare, Inc. 1313 North Market Street, Suite 1000 Wilmington DE DELAWARE 19801 Director Other Health Care Decline to Disclose 06b false 2025-08-01 false true true false 0 6744266 6144268 599998 Amounts include conversion of outstanding convertible notes and simple agreements for future equity. In addition, the Company has offered 10-year warrants to purchase up to a maximum of 101,891 shares at $2.9443 per share. false 12 0 0 0 false RxWare, Inc. /s/ Raeanna Lewarne Raeanna Lewarne Chief Executive Officer 2025-08-14